Loading...

Clinical Decision Dynamics Study

Human Values Project

You are a practicing clinician taking care of the following patient. Based on the case details, please indicate your action.

History of Present Illness

A 72-year-old Vietnamese-speaking woman with HLD, HTN, CKD stage II (baseline creatinine 1.3), and cholelithiasis is admitted for severe gallstone pancreatitis.

Past Medical / Surgical History

Condition
Hyperlipidemia
Hypertension
Cholelithiasis
CKD stage II
History of positive PPD

Family History

Relative Condition
First-degree relatives Heart disease
Diabetes

Social History

Factor Details
Tobacco Former smoker
Alcohol 1–2 drinks daily
Living situation Lives with son & daughter-in-law
Marital status Widowed
Occupation Former textile factory manager
Insurance Commercial

Home Medications on Admission

Medication Dose Frequency Notes
Atorvastatin 40 mg qHS
Lisinopril 5 mg qD
Ibuprofen 400–800 mg qD PRN For joint pain

Physical Exam on Admission

Vital Sign Value
Temperature 101.3 °F
Heart Rate 112 bpm
Blood Pressure 98/52 mm Hg
SpO₂ 93 % RA
Respiratory Rate 24 /min
System Findings
General Alert, oriented, NAD, appears very fatigued
HEENT Mild scleral icterus
CV Tachycardic, regular rhythm, no m/r/g
Lungs Bilateral basal crackles
Abdomen Soft, mildly distended, TTP RUQ/peri-umbilical
Extremities No LE edema
MSK No joint swelling

Admission Data

Test Result
CBC WBC 17.3 K, Hgb 10.2 g/dL, Plt 345 K
BMP Cr 1.8 mg/dL, BUN 45 mg/dL
LFTs Alk P 102 U/L, Tbili 3.2 mg/dL
Lipase 603 U/L
CT A/P Peripancreatic stranding; cholelithiasis; intrahepatic biliary ductal dilatation

Hospital Course Highlights

  • Severe sepsis & ARDS → 6 L O₂ → ICU → broad spectrum antibiotics
  • CXR: lung nodule → outpatient biopsy recommendation
  • DVT → heparin drip → apixaban
  • Respiratory failure → intubation → 57-day stay → gradual recovery
  • Lung nodule plan deferred → severe deconditioning → rehab

Discharge Medications

Medication Dose & Timing Notes
Atorvastatin 40 mg qHS
Lisinopril 5 mg qD On HOLD until PCP follow-up
Ibuprofen 400–800 mg qD PRN On HOLD due to AKI on CKD
Acetaminophen 1000 mg q8h PRN
Potassium chloride 20 mEq daily
Apixaban 5 mg BID

Discharge Physical Exam

Vital Sign Value
Temperature 97.3 °F
Heart Rate 85 bpm
Blood Pressure 142/75 mm Hg
SpO₂ 95 % RA
Respiratory Rate 18 /min
System Findings
General Alert, oriented, NAD, appears weak
HEENT No scleral icterus; no oral lesions
CV RRR; no m/r/g
Lungs CTAB; no c/r/w
Abdomen Soft, non-distended, non-tender
Extremities No LE edema
MSK No joint swelling

Discharge Labs

Test Result
WBC 10.5 K
Hgb 8.3 g/dL
Plt 473 K
Sodium 137 meq/L
Potassium 3.4 meq/L
Chloride 104 meq/L
Bicarbonate 21 meq/L
BUN 26 mg/dL
Creatinine 1.5 mg/dL

Decision-Making

As you prepare discharge paperwork, you recall the lung nodule. No biopsy plan exists but PCP follow-up within 7 days is possible, and rehab offers transport. You discuss inpatient biopsy versus outpatient management; the patient prefers conservative management and defers to your recommendation.

Decision: Would you discharge the patient at this time?

Please select your decision: